title: Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.
abstract: Exendin 4 (Ex4) is a glucagon-like peptide-1 receptor (GLP- 1R) agonist which is available as a short-acting injectable treatment for type 2 diabetes. Our aim was to characterize the long-term effects of elevated steady-state levels of Ex4 provided by in vivo gene therapy. We constructed a helper-dependent adenoviral (HDAd) vector for long-term expression of Ex4 in vivo. A high-fat diet (HFD)-induced obesity (DIO) mouse model was chosen to approximate the metabolic derangements seen in obese patients. Mice were treated with a single injection of HDAd-Ex4 and were monitored for 15 weeks. Both hepatic Ex4 RNA and plasma Ex4 were detectable at the end of the study. HDAd-Ex4 treatment improved glucose homeostasis without increasing insulin levels. However, there was evidence of enhanced insulin action and decreased gluconeogenic enzyme expression. HDAd-Ex4 caused decreased weight gain without detectable changes in food intake, in part, due to increases in energy expenditure (EE). HDAd-Ex4 DIO mice also had reduced hepatic fat and an improved adipokine profile. In the liver, there was decreased expression of genes that were involved in de novo fatty acid synthesis. These observations are important in considering the development of longer acting GLP-1R agonists for the treatment of type 2 diabetes.
authors.affiliation: Division of Diabetes and Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: Susan L
authors.initials: SL
authors.lastname: Samson
authors.forename: Erica V
authors.initials: EV
authors.lastname: Gonzalez
authors.forename: Vijay
authors.initials: V
authors.lastname: Yechoor
authors.forename: Mandeep
authors.initials: M
authors.lastname: Bajaj
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Oka
authors.forename: Lawrence
authors.initials: L
authors.lastname: Chan
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D002478:Cells, Cultured; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000628:therapy*; D004041:Dietary Fats; D004435:Eating; D000077270:Exenatide; D015316:Genetic Therapy; D005822:Genetic Vectors; D000067757:Glucagon-Like Peptide-1 Receptor; D005947:Glucose / Q000378:metabolism; D006378:Helper Viruses / Q000235:genetics*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D009765:Obesity / Q000209:etiology / Q000628:therapy*; D010455:Peptides / Q000235:genetics*; D018027:Receptors, Glucagon / Q000819:agonists; D014688:Venoms / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D004041:Dietary Fats; C000593834:Glp1r protein, mouse; D000067757:Glucagon-Like Peptide-1 Receptor; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D000077270:Exenatide; D005947:Glucose
references.citation: Diabetes. 2004 May;53(5):1326-35
references.pmid: 15111503
references.citation: Horm Metab Res. 2004 Nov-Dec;36(11-12):830-6
references.pmid: 15655715
references.citation: Diabetes. 1994 Apr;43(4):535-9
references.pmid: 8138058
references.citation: Diabetes. 2007 Jun;56(6):1671-9
references.pmid: 17369525
references.citation: Mol Ther. 2003 Apr;7(4):478-83
references.pmid: 12727110
references.citation: Gene Ther. 2007 Jan;14(1):38-48
references.pmid: 16929351
references.citation: J Biol Chem. 2006 Jul 14;281(28):18933-41
references.pmid: 16687413
references.citation: Endocrinology. 2005 Apr;146(4):2069-76
references.pmid: 15618356
references.citation: J Biol Chem. 2000 Nov 3;275(44):34471-7
references.pmid: 10952981
references.citation: Trends Endocrinol Metab. 2007 Aug;18(6):240-5
references.pmid: 17629492
references.citation: Can J Biochem Physiol. 1959 Aug;37(8):911-7
references.pmid: 13671378
references.citation: J Am Soc Nephrol. 2007 Apr;18(4):1227-38
references.pmid: 17360951
references.citation: Trends Endocrinol Metab. 2008 Mar;19(2):65-73
references.pmid: 18291668
references.citation: Diabetes. 2000 Mar;49(3):424-30
references.pmid: 10868964
references.citation: Gastroenterology. 2004 Aug;127(2):546-58
references.pmid: 15300587
references.citation: Biochem Pharmacol. 2002 Mar 1;63(5):993-6
references.pmid: 11911852
references.citation: Gene Ther. 2007 Feb;14(3):191-202
references.pmid: 16957769
references.citation: J Appl Physiol (1985). 2004 Sep;97(3):991-7
references.pmid: 15133003
references.citation: Am J Clin Nutr. 2006 Sep;84(3):556-60
references.pmid: 16960169
references.citation: Curr Protoc Mol Biol. 2005 Feb;Chapter 16:Unit 16.24
references.pmid: 18265354
references.citation: Gene Ther. 2007 Jan;14(2):162-72
references.pmid: 16943856
references.citation: Mol Cell Endocrinol. 2003 Jun 30;204(1-2):43-50
references.pmid: 12850280
references.citation: Diabetologia. 2005 Jul;48(7):1380-5
references.pmid: 15915337
references.citation: Biochem Biophys Res Commun. 2005 Oct 14;336(1):215-22
references.pmid: 16125673
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1427-35
references.pmid: 12776726
references.citation: Hepatology. 2004 Oct;40(4):783-6
references.pmid: 15382158
references.citation: Peptides. 2006 Jan;27(1):157-64
references.pmid: 16154233
references.citation: Diabetes. 1999 May;48(5):1026-34
references.pmid: 10331407
references.citation: Pharmacol Rev. 2003 Mar;55(1):167-94
references.pmid: 12615957
references.citation: Gastroenterology. 2008 Feb;134(2):556-67
references.pmid: 18242221
references.citation: Physiol Rev. 2007 Oct;87(4):1409-39
references.pmid: 17928588
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):943-8
references.pmid: 17213311
references.citation: Diabetes. 2008 Feb;57(2):288-97
references.pmid: 17977951
references.citation: FEBS Lett. 1997 Sep 29;415(2):134-8
references.pmid: 9350983
references.citation: Gastroenterology. 2008 Apr;134(4):1137-47
references.pmid: 18313669
references.citation: Diabetes. 2006 Jun;55(6):1562-70
references.pmid: 16731818
references.citation: J Biol Chem. 2003 Dec 19;278(51):51664-72
references.pmid: 14534295
references.citation: Int J Obes Relat Metab Disord. 2000 Mar;24(3):288-98
references.pmid: 10757621
references.citation: Diabetes Care. 2007 Jun;30(6):1487-93
references.pmid: 17353504
references.citation: Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E671-8
references.pmid: 12626323
references.citation: Diabetes. 2007 Jan;56(1):8-15
references.pmid: 17192459
references.citation: Diabetes Obes Metab. 2008 Sep;10(10):921-30
references.pmid: 18093209
references.citation: Hum Gene Ther. 1999 Nov 1;10(16):2667-72
references.pmid: 10566894
references.citation: Cell Metab. 2007 Dec;6(6):484-96
references.pmid: 18054317
references.citation: Diabetes. 2006 Dec;55(12):3387-93
references.pmid: 17130484
references.citation: Hepatology. 2006 Jan;43(1):173-81
references.pmid: 16374859
references.citation: J Biol Chem. 1992 Apr 15;267(11):7402-5
references.pmid: 1313797
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):937-42
references.pmid: 17213325
references.citation: World J Gastroenterol. 2007 Jul 14;13(26):3540-53
references.pmid: 17659704
references.citation: J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
references.pmid: 15181022